SYTELGY Trademark
SYTELGY is a USPTO trademark filed by OCUGEN, INC.. Status: Pending.
Trademark Facts
| Mark | SYTELGY |
|---|---|
| Serial Number | 99012187 |
| Status | Pending |
| Filing Date | 2025-01-18 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | OCUGEN, INC. |
| Attorney of Record | Don D. Cha |
| Prosecution Events | 13 |
| Latest Event | EXRA on 2026-04-05 |
Goods & Services
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Gene therapy products, namely, recombinant adeno-associated virus (rAAV) vector for treating ocular diseases; Gene therapy products, namely, recombinant adeno-associated virus (rAAV) vector for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant nucleic acid for treating ocular diseases; Gene therapy products, namely, recombinant nucleic acid for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant DNA for treating ocular diseases; Gene therapy products, namely, recombinant DNA for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant rAAV for treating ocular diseases such as Leber congenital amaurosis (LCA), retinitis pigmentosa, enhance S-cone syndrome, Goldmann Favre syndrome, rod-cone dystrophy Bardet-Biedl Syndrome, Achromatopsia, Best Disease (vitelliform macular degeneration), Bardet-Biedl Syndrome, Choroideremia, Macular Degeneration, Stargardt Disease, X-Linked Retinoschisis (XLRS), X-Linked Retinitis Pigmentosa (XLRP), Usher Syndrome, cone-rod dystrophy, Dry-Age related macular degeneration, and wet-Age related macular degeneration